Evaluating the Impact of a Meta Quest 3 Gamified VR Rehabilitation Program in Knee Osteoarthritis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-64
SponsorUmm Al-Qura University

About this trial

The goal of this clinical trial is to learn if a gamified virtual reality (VR) rehabilitation program can effectively reduce pain, improve functionality, and enhance balance in adults aged 40-64 years diagnosed with knee osteoarthritis. The main questions it aims to answer are:

Can the VR rehabilitation program reduce pain and disability compared to conventional physical therapy alone? Can the VR rehabilitation program improve balance and functionality in patients with knee osteoarthritis? Researchers will compare a group receiving the VR-based rehabilitation program alongside conventional therapy to a group receiving only conventional therapy to see if the addition of VR leads to superior outcomes.

Participants will:

Undergo either VR-based rehabilitation combined with conventional therapy or conventional therapy alone.

Complete assessments at three time points (baseline, 3 weeks, and 7 weeks) using measures such as pain scales, disability indices, and balance tests.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age: 40-64 years

Diagnosis: Knee OA (Stages 2 or 3 based on American College of Rheumatology criteria)

Ability to read and understand Arabic

Disqualifiers

Recent lower extremity surgery/fractures

Other rheumatologic or cardiovascular conditions

Visual/auditory impairments

Dizziness or vertigo

Trial design

Design model

Parallel

Treatments tested in this trial

  • Meta Quest 3 Virtual Reality

    Device

    Immersive virtual reality Meta Quest 3 device

  • Exercise

    Procedure/Surgery

    Traditional exercise program for knee OA patients

  • Electrotherapy

    Device

    Electrotherapy including Therapeutic Ultrasound (US) and Transcutaneous Electrical Nerve Stimulation (TENS)

Treatment groups

90 Participants
are divided into 2 treatment groups
Group A: conventional therapy control groupActive comparator 2 interventions
Group B: Experimental VR-based GroupExperimental treatment 3 interventions

Trial outcomes

Primary outcomes

1

Pain

Visual Analog Scale (VAS)

Time frame
From enrolment to the end of treatment at 7 weeks
2

Function

six-Minute Walk Test (6MWT)

Time frame
From enrolment to the end of treatment at 7 weeks
3

Disability

Western Ontario and McMaster Universities Arthritis Index (WOMAC)

Time frame
From enrolment to the end of treatment at 7 weeks
4

Balance

Berg Balance Scale

Time frame
From enrolment to the end of treatment at 7 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: